Medical Devices
Bioresorbable Vascular Scaffold Market

Bioresorbable Vascular Scaffold Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Bioresorbable Vascular Scaffold Market by Product (Metal Bioresorbable Vascular Scaffold, Polymer Bioresorbable Vascular Scaffold), Application (Peripheral Artery, Coronary Artery), End-user (Hospitals, Ambulatory Care Centers, Cardiac Centers, Others), and Regional Analysis for 2025 - 2032

ID: PMRREP34715

June 2025

192 Pages

Author : Abhijeet Surwase

Healthcare

Market Dynamics

Driver - Growing prevalence of CVD and CAD to boost market growth

According to a 2023 report released by the World Heart Federation (WHF), CVD killed over 20 million people worldwide in 2021, emerging as the leading cause of death globally. Moreover, the American Heart Association revealed in a 2024 report that around 5% of Americans aged under 20 suffer from CAD. Patients afflicted by CVD or CAD often seek low-risk treatments with faster recovery times. Minimally invasive procedures (MIS) fulfil this preference among heart patients, with bioresorbable vascular scaffolds providing an efficient alternative to traditional surgical techniques. The alignment between changing patient preferences and rapid advancements in interventional cardiology will propel the bioresorbable scaffolds market growth in the upcoming years. The incorporation of digital health solutions will also play a central role in the adoption of bioresorbable vascular scaffold in the near future.

Restraint - Biocompatibility concerns to dampen the market outlook

Concerns surrounding the biocompatibility of bioresorbable vascular scaffolds arise from the uncertainty of the body’s response to the scaffold material. This response, in turn, is likely to affect tissue integration and the overall healing process. On the other hand, the material used needs to have sufficient mechanical strength to support the body’s vascular structure while it degrades at a controlled rate. Addressing these interconnected challenges requires huge upfront investments in research & development activities, which can prove to be a major hurdle in the growth of the BVS market.

Opportunity - Supportive regulations and rising R&D investments to enhance the bioresorbable vascular scaffold market

The bioresorbable vascular scaffold industry is expected to make gains due to an increasingly favorable regulatory environment for innovative medical devices and procedures. Regulatory bodies are expediting the approval of new-age treatment options such as BVS, enabling quick market entry to health-tech companies specializing in cardiac products and services. Additionally, the market is set to benefit from significant investments being made in R&D activities in this field. For example, in May 2024, a California-based healthcare technology company called R3 Vascular, raised US$ 87 million to develop bioresorbable scaffolds to treat peripheral arterial disease. The BVS market is poised for speedy expansion as a result of these innovation opportunities.

Get Your CustomizationGet Your Customization

Category-wise Analysis

Product Insights

Based on product, the bioresorbable vascular scaffold market has been divided into metal bioresorbable vascular scaffold and polymer bioresorbable vascular scaffold. The polymer BVS segmented is set to lead the product category with a share of 89.7% in 2025. Polymer-based scaffolds are gaining traction due to their superior biocompatibility and controlled degradation rates, which align with the body's healing process. Innovations in biodegradable polymers and scaffold architecture are enhancing performance metrics such as radial strength and flexibility, positioning polymer scaffolds as a key growth driver.

Application Insights

Based on application, the bioresorbable vascular scaffold market has been segmented into coronary artery and peripheral artery. The market share for coronary artery is anticipated to dominate the market during the forecast period with a positive CAGR through 2032. The emergence of CAD as a leading cause of death worldwide in recent years and the growing demand for minimally invasive surgeries with faster recovery periods are the two primary factors driving this segment. Moreover, advancements in bioresorbable vascular scaffolds have made them more efficient and safer, increasing their adoption among cardiac patients and healthcare professionals alike.

End-user Insights

By end-user, the segmentation includes hospitals, ambulatory care centers, cardiac centers, and others. Among these hospitals are expected to showcase a leading CAGR through 2032, holding a major share in the bioresorbable vascular scaffold market. Hospitals are the most preferred locations for cardiovascular treatments due to the availability of healthcare professionals and advanced medical infrastructure.

bioresorbable vascular scaffold market insights and key trends

Regional Insights

North America Bioresorbable Vascular Scaffold Market Trends

North America dominates the bioresorbable vascular scaffold market and is expected to grow at a 7.70% CAGR through 2032. The region boasts a robust healthcare infrastructure, high spending ability, and strong healthcare expenditure, enabling swift adoption of next-generation medical technologies such as BVS. Additionally, rising incidence of CVD and CAD among the US population will further boost the regional market. Favorable regulations and heavy investments in healthcare R&D are also key factors driving the bioresorbable scaffolds market in North America.

East Asia Bioresorbable Vascular Scaffold Market Trends

East Asia Market is projected to secure a CAGR of 9.21% in the forecast period by 2032. The region’s increasing healthcare expenditure and advancements in medical technology drive demand for innovative cardiovascular treatments. Furthermore, growing awareness among healthcare professionals and patients about the benefits of bioresorbable scaffolds over traditional stents is accelerating the adoption.

Additionally, favorable government initiatives supporting the development of healthcare infrastructure and the rising incidence of cardiovascular diseases contribute to market growth. With expanding access to advanced healthcare facilities and a rise in an aging population prone to cardiac ailments, East Asia offers more opportunities for market expansion.

Request Free sampleRequest Free sample

Competitive Landscape

The global bioresorbable vascular scaffold market is competitive. Growing R&D investments to develop, launch, and expand the product portfolio is a key strategy observed in the last couple of years. The leading industry players are expanding their manufacturing capabilities and simultaneously their presence in the global industry.

Key Industry Developments:

In April 2024, Abbott’s Esprit™ BTK System received FDA approval for treating chronic limb-threatening ischemia (CLTI) below the knee. It delivers Everolimus, supports vessel healing, and fully dissolves over time.
In February 2024, Biotronik launched Freesolve™ Resorbable Magnesium Scaffold (RMS) and secured CE approval. As a third-generation RMS, it enables magnesium resorption within 12 months, offering optimized support for vascular healing.
In June 2023, Zeus introduced Absorv™ XSE oriented tubing, a next-gen solution for bioresorbable vascular scaffolds, providing a viable alternative to permanent metallic implants.

Companies Covered in Bioresorbable Vascular Scaffold Market

Meril Life Sciences Pvt. Ltd.
Zeus Company LLC
Biotronik
Abbott
MicroPort Scientific Corporation
Kyoto Medical
Elixir Medical (MedImpact Healthcare Systems, Inc.)
Cigna
B. Braun Melsungen AG
Boston Scientific Corporation
REVA Medical

Frequently Asked Questions

The market is projected to reach US$ 314.4 million in 2025.

The rising incidence of cardiovascular disease and coronary heart disease, along with a growing preference for minimally invasive heart procedures, are the key market drivers.

The market is poised to witness a CAGR of 8.3% from 2025 to 2032.

An increasingly favorable regulatory environment for innovative medical devices and procedures, and significant investments being made in R&D activities, are the key market opportunities.

Meril Life Sciences Pvt. Ltd., Zeus Company LLC, and Biotronik SE & Co. are some key players in the bioresorbable vascular scaffold market.

Top-Down Market Sizing	Bottom-Up Market Sizing
Universe Definition: Total global/regional market identification	Unit Economics: Average transaction values, purchase frequencies, customer lifecycle
Segmentation Filters: Geographic, demographic, and behavioral constraints	Customer Segmentation: Detailed buyer persona development and sizing
Market Share Analysis: Competitive landscape assessment and share allocation	Penetration Analysis: Market penetration rates by segment and geography
Growth Rate Application: Historical trends and forward-looking growth assumptions	Scaling Methodology: Extrapolation techniques with confidence intervals

Interested in this report?

Request customization, ask for expert consulting, access a sample report, or simply express your interest—our team will assist you with the right insights and solutions.

Request Custom VersionRequest Custom Version

Clients

Media Citation

Get In Touch

Loading page data

Please wait a moment

Executive Summary
1. Global Bioresorbable Vascular Scaffold Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Mn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Key Trends
3. Macro-economic Factors
  1. The development of biodegradable polymers and next-gen scaffold designs
  2. Engineering of novel polymers with improved biocompatibility and controlled degradation rates
4. COVID-19 Impact Analysis
5. Forecast Factors - Relevance and Impact
Value Added Insights
1. Tool Adoption Analysis
2. Regulatory Landscape
3. Value Chain Analysis
4. PESTLE Analysis
5. Porter’s Five Force Analysis
Price Analysis, 2024A
1. Key Highlights
2. Key Factors Impacting Deployment Costs
3. Pricing Analysis, By Enterprise Type
Global Bioresorbable Vascular Scaffold Market Outlook
1. Key Highlights
  1. Market Volume (Units) Projections
  2. Market Size (US$ Mn) and Y-o-Y Growth
  3. Absolute $ Opportunity
2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast
  1. Historical Market Size (US$ Mn) Analysis, 2019-2024
  2. Market Size (US$ Mn) Analysis and Forecast, 2025 - 2032
3. Global Bioresorbable Vascular Scaffold Market Outlook: Product
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019 - 2024
  3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
    1. Metal Bioresorbable Vascular Scaffold
    2. Polymer Bioresorbable Vascular Scaffold
  4. Market Attractiveness Analysis: Product
4. Global Bioresorbable Vascular Scaffold Market Outlook: Application
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By Application, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
    1. Peripheral Artery
    2. Coronary Artery
  4. Market Attractiveness Analysis: Application
5. Global Bioresorbable Vascular Scaffold Market Outlook: End-user
  1. Introduction / Key Findings
  2. Historical Market Size (US$ Mn) Analysis, By End-user, 2019 - 2024
  3. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025 - 2032
    1. Hospitals
    2. Ambulatory Surgical Centers
    3. Cardiac Catheterization Labs
    4. Others
  4. Market Attractiveness Analysis: End-user
Global Bioresorbable Vascular Scaffold Market Outlook: Region
1. Key Highlights
2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Region, 2019 - 2024
3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Region, 2025 - 2032
  1. North America
  2. Europe
  3. East Asia
  4. South Asia and Oceania
  5. Latin America
  6. Middle East & Africa
4. Market Attractiveness Analysis: Region
North America Bioresorbable Vascular Scaffold Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Application
  4. By End-user
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. U.S.
  2. Canada
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. 1. Metal Bioresorbable Vascular Scaffold
    2. Polymer Bioresorbable Vascular Scaffold
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Peripheral Artery
  2. Coronary Artery
6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Cardiac Catheterization Labs
  4. Others
7. Market Attractiveness Analysis
Europe Bioresorbable Vascular Scaffold Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Application
  4. By End-user
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Türkiye
  8. Rest of Europe
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. 1. Metal Bioresorbable Vascular Scaffold
    2. Polymer Bioresorbable Vascular Scaffold
5. Market Size (US$ Mn) Analysis and Forecast, Application, 2025 - 2032
  1. Peripheral Artery
  2. Coronary Artery
6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025 - 2032
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Cardiac Catheterization Labs
  4. Others
7. Market Attractiveness Analysis
East Asia Bioresorbable Vascular Scaffold Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Application
  4. By End-user
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. China
  2. Japan
  3. South Korea
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. 1. Metal Bioresorbable Vascular Scaffold
    2. Polymer Bioresorbable Vascular Scaffold
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Peripheral Artery
  2. Coronary Artery
6. Market Size (US$ Mn) Analysis and Forecast, End-user, 2025 - 2032
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Cardiac Catheterization Labs
  4. Others
7. Market Attractiveness Analysis
South Asia & Oceania Bioresorbable Vascular Scaffold Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Application
  4. By End-user
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. India
  2. Southeast Asia
  3. ANZ
  4. Rest of South Asia & Oceania
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. 1. Metal Bioresorbable Vascular Scaffold
    2. Polymer Bioresorbable Vascular Scaffold
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Peripheral Artery
  2. Coronary Artery
6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Cardiac Catheterization Labs
  4. Others
7. Market Attractiveness Analysis
Latin America Bioresorbable Vascular Scaffold Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Application
  4. By End-user
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. 1. Metal Bioresorbable Vascular Scaffold
    2. Polymer Bioresorbable Vascular Scaffold
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Peripheral Artery
  2. Coronary Artery
6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Cardiac Catheterization Labs
  4. Others
7. Market Attractiveness Analysis
Middle East & Africa Bioresorbable Vascular Scaffold Market Outlook
1. Key Highlights
2. Historical Market Size (US$ Mn) Analysis, By Market, 2019 - 2024
  1. By Country
  2. By Product
  3. By Application
  4. By End-user
3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025 - 2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025 - 2032
  1. 1. Metal Bioresorbable Vascular Scaffold
    2. Polymer Bioresorbable Vascular Scaffold
5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025 - 2032
  1. Peripheral Artery
  2. Coronary Artery
6. Market Size (US$ Mn) Analysis and Forecast, By End-user, 2025 - 2032
  1. Hospitals
  2. Ambulatory Surgical Centers
  3. Cardiac Catheterization Labs
  4. Others
7. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping By Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. Meril Life Sciences Pvt. Ltd.
    1. Overview
    2. Segments and Deployments
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Zeus Company LLC
  3. Biotronik
  4. Abbott
  5. MicroPort Scientific Corporation
  6. Kyoto Medical
  7. Elixir Medical
  8. Cigna
  9. B. Braun Melsungen AG
  10. Boston Scientific Corporation
  11. REVA Medical
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Bn/Mn, Volume: As Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Latin America Middle East and Africa
Segmental Coverage	Product Application End-user Region
Competitive Analysis	Meril Life Sciences Pvt. Ltd. Zeus Company LLC Biotronik Abbott MicroPort Scientific Corporation Kyoto Medical Elixir Medical (MedImpact Healthcare Systems, Inc.) Cigna B. Braun Melsungen AG Boston Scientific Corporation REVA Medical
Report Highlights	Market Forecast and Trends Competitive Intelligence and Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools
Customization and Pricing	Available upon request

Report Attribute	Details
Historical Data/Actuals	2019 - 2024
Forecast Period	2025 - 2032
Market Analysis Units	Value: US$ Bn/Mn, Volume: As Applicable
Geographical Coverage	North America Europe East Asia South Asia and Oceania Latin America Middle East and Africa
Segmental Coverage	Product Application End-user Region
Competitive Analysis	Meril Life Sciences Pvt. Ltd. Zeus Company LLC Biotronik Abbott MicroPort Scientific Corporation Kyoto Medical Elixir Medical (MedImpact Healthcare Systems, Inc.) Cigna B. Braun Melsungen AG Boston Scientific Corporation REVA Medical
Report Highlights	Market Forecast and Trends Competitive Intelligence and Share Analysis Growth Factors and Challenges Strategic Growth Initiatives Pricing Analysis Future Opportunities and Revenue Pockets Market Analysis Tools
Customization and Pricing	Available upon request

Bioresorbable Vascular Scaffold Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Bioresorbable Vascular Scaffold Market by Product (Metal Bioresorbable Vascular Scaffold, Polymer Bioresorbable Vascular Scaffold), Application (Peripheral Artery, Coronary Artery), End-user (Hospitals, Ambulatory Care Centers, Cardiac Centers, Others), and Regional Analysis for 2025 - 2032